Retinal and Visual Pathways Involvement in Carriers of Friedreich’s Ataxia
暂无分享,去创建一个
A. Grzybowski | C. Casali | E. Cioffi | V. Parisi | L. Ziccardi | G. Antonelli | A. Di Renzo | C. Marcotulli | Lucilla Barbano | Valeria Gioiosa
[1] L. Frishman,et al. ISCEV Standard for full-field clinical electroretinography (2022 update) , 2022, Documenta Ophthalmologica.
[2] J. Salazar,et al. Neuro-Ophthalmological Findings in Friedreich’s Ataxia , 2021, Journal of personalized medicine.
[3] Michael Bach,et al. ISCEV standard for clinical multifocal electroretinography (mfERG) (2021 update) , 2021, Documenta Ophthalmologica.
[4] V. Parisi,et al. Correlations between visual morphological, electrophysiological, and acuity changes in chronic non-arteritic ischemic optic neuropathy , 2021, Graefe's Archive for Clinical and Experimental Ophthalmology.
[5] M. Varano,et al. Macular Functional and Morphological Changes in Intermediate Age-Related Maculopathy , 2020, Investigative ophthalmology & visual science.
[6] P. Barboni,et al. Functional Changes of Retinal Ganglion Cells and Visual Pathways in Patients with Chronic Leber's Hereditary Optic Neuropathy during One Year of Follow-up. , 2019, Ophthalmology.
[7] E. Mermeklieva. Pattern electroretinography and retinal changes in patients with diabetes mellitus type 2 , 2019, Neurophysiologie Clinique.
[8] M. Parravano,et al. Early and localized retinal dysfunction in patients with type 1 diabetes mellitus studied by multifocal electroretinogram , 2018, Acta Diabetologica.
[9] M. Carbonelli,et al. Patterns of Retinal Ganglion Cell Damage in Neurodegenerative Disorders: Parvocellular vs Magnocellular Degeneration in Optical Coherence Tomography Studies , 2017, Front. Neurol..
[10] K. Bürk. Friedreich Ataxia: current status and future prospects , 2017, Cerebellum & Ataxias.
[11] Pablo Villoslada,et al. The APOSTEL recommendations for reporting quantitative optical coherence tomography studies , 2016, Neurology.
[12] L. Corben,et al. Characterization of the retinal pigment epithelium in Friedreich ataxia , 2015, Biochemistry and biophysics reports.
[13] K. Örnek,et al. Optical Coherence Tomography and Visual Field Findings in Patients With Friedreich Ataxia , 2014, Journal of neuro-ophthalmology.
[14] R. Roxburgh,et al. Ophthalmic manifestations of inherited neurodegenerative disorders , 2014, Nature Reviews Neurology.
[15] G. Savini,et al. Retinal function and neural conduction along the visual pathways in affected and unaffected carriers with Leber's hereditary optic neuropathy. , 2013, Investigative ophthalmology & visual science.
[16] P. Giunti,et al. Clinical features of Friedreich's ataxia: classical and atypical phenotypes , 2013, Journal of neurochemistry.
[17] K. Bushara,et al. Analysis of the visual system in Friedreich ataxia , 2013, Journal of Neurology.
[18] J. Arpa,et al. Ophthalmic features of Friedreich ataxia , 2012, Eye.
[19] J. Camadro,et al. Inactivation of mitochondrial aspartate aminotransferase contributes to the respiratory deficit of yeast frataxin-deficient cells. , 2012, The Biochemical journal.
[20] Michael Bach,et al. ISCEV standard for clinical visual evoked potentials (2009 update) , 2010, Documenta Ophthalmologica.
[21] P. Barboni,et al. Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders. , 2009, Biochimica et biophysica acta.
[22] G. Coppola,et al. Electrophysiological assessment of visual function in patients with non‐arteritic ischaemic optic neuropathy , 2008, European journal of neurology.
[23] P. Anslow,et al. Catastrophic visual loss in a patient with Friedreich ataxia. , 2007, Archives of ophthalmology.
[24] J. Szlyk,et al. Retinal Dysfunction in Carriers of Bardet-Biedl Syndrome , 2007, Ophthalmic genetics.
[25] L. Levin,et al. Pathophysiology of the optic neuropathy associated with Friedreich ataxia. , 2003, Archives of ophthalmology.
[26] L. Schöls,et al. Heterozygous expansion of the GAA tract of the X25/frataxin gene is associated with insulin resistance in humans. , 2000, Diabetes.
[27] P Trouillas,et al. Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. , 1997, Human molecular genetics.
[28] M. Pandolfo,et al. Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. , 1997, Science.
[29] P. Patel,et al. Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion , 1996, Science.
[30] G. Pozzessere,et al. Early Detection of Neurological Involvement in IDDM and NIDDM: Multimodal Evoked Potentials Versus Metabolic Control , 1988, Diabetes Care.
[31] R. Baloh,et al. Eye movements in Friedreich's ataxia. , 1983, Archives of neurology.
[32] S. Coupland,et al. An Electroretinal and Visual Evoked Potential Study in Friedreich’s Ataxia , 1981, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[33] D. Spinelli,et al. The ERG in response to alternating gratings in patients with diseases of the peripheral visual pathway. , 1981, Investigative ophthalmology & visual science.
[34] R. Jampel,et al. Square wave jerks in Friedreich's ataxia. , 1978, American journal of ophthalmology.
[35] D. Manners,et al. Visual system involvement in patients with Friedreich's ataxia. , 2009, Brain : a journal of neurology.
[36] V. Parisi,et al. Visual electrophysiological responses in persons with type 1 diabetes , 2001, Diabetes/metabolism research and reviews.
[37] V. Scaioli,et al. Visual involvement in Friedreich's ataxia: PERG and VEP study. , 1988, European Neurology.
[38] G. Celesia. Evoked potential techniques in the evaluation of visual function. , 1984, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.